Utility of volume adjusted prostate specific antigen density in the diagnosis of prostate cancer in Arab men

International Urology and Nephrology

Volumn 37, Issue 4, 2005, Pages 721-726

  Sheikh, Mehraj ^a   Al Saeed, O ^a   Kehinde, E O ^a   Sinan, T ^a   Anim, J T ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Arab men; Diagnosis; Prostate cancer; Prostate specific antigen density

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARAB; ARTICLE; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIGITAL RECTAL EXAMINATION; HISTOPATHOLOGY; HUMAN; KUWAIT; MAJOR CLINICAL STUDY; MALE; MAXIMUM LIKELIHOOD METHOD; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROTEIN BLOOD LEVEL; ROC CURVE; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ARABS; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 31144465267     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-005-4683-2     Document Type: Article

References (38)

1. Morgan TO, Jacobsen SJ, Mc Carthy WF et al. Age specific references ranges for serum prostate-specific antigen in black men. N Engl Med 1996; 335: 304-310. 10.1056/NEJM199608013350502 1:STN:280:BymB1czhsVI%3D
2. Kehinde EO, Sheikh M, Francis I et al. Diagnostic dilemma in men with high PSA in the Middle East. Eur Urol 2000; 38: 506.
3. Kehinde O.E. Sheikh M. Mojimoniyi O.A. et al. High serum prostate specific antigen levels in the absence of prostate cancer in Middle eastern men: The clinicians dilemma. BJU (Int) 2000 91 618-622
4. Selmy G. The value of TRUS in the ultrasonographic unit. Afr J Urol 1998; 4: 93-97.
5. Toktas G, Unluer E, Aglamis E et al. Effects of chronic prostatitis on prostate specific antigen. Br J Urol (Int) 2000; 86(Suppl 3), 104.
6. Tan YH, Tan KY, Foo KT. The role of a trial of antibiotics in asymptomatic patients with elevated prostate specific antigen - an Asian perspective. Br J Urol (Int) 2000; 86(Suppl 3), 104.
7. Benson MC, Seong W, Allan P et al. Prostate specific antigen density: A means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992; 147: 815-816. 1371554 1:STN:280:By2C28jkt1Y%3D
8. Hodge KK, Mc Neal JE, Terris MK, Stamey TA. Random systematic versus direct ultrasound guided transrectal core biopsies of the prostate. J Urol 1989; 142: 71. 2659827 1:STN:280:BiaB1c%2FgslY%3D
9. Bermann J, Moro W, Edgar LCL, George FM. Elevated prostate-specific antigen and the negative prostate biopsy. South Med J 1994; 87: 290-291.
10. Osterling JE. Prostate-specific antigen: A critical assessment of the most useful marker for adenocarcinoma of the prostate. J Urol 1991; 145: 907-923.
11. Catalona WJ, Smith DS, Ratliffe TL et al. Measurement of prostate- specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991; 324: 1156-1161. 1707140 1:STN:280:By6C1cjgslY%3D
12. Babaian RJ, Campus JL. The role of prostate-specific antigen as a part of the diagnostic triad and as a guide when to perform a biopsy. Cancer 1991; 68: 2060-2063. 1717134 1:STN:280:By2D3crjt1Q%3D A1991GK16800034
13. Barak M, Mecz Y, Lurie A, Gruener N. Evaluation of prostate-specific antigen as a marker for adenocarcinoma of the prostate. Lab Clin Med 1989; 113: 598-603. STN:280:BiaB3srktlw%3D
14. Carter HB, Pearson JD, Metter EJ et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 1992; 267: 2215-2220. 1372942 1:STN:280:By2B3M7nvVM%3D A1992HN84100032
15. Joseph EO. Age specific reference ranges for serum PSA. New Eng J Med 1996; 335: 345-346.
16. Gohji K, Nomi M, Egawa S et al. Detection of prostate carcinoma using prostate-specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate-specific antigen concentrations. Cancer 1997; 79: 1969-1976. 10.1002/(SICI)1097-0142(19970515)79:10<1969::AID-CNCR19>3.0.CO;2-T 9149025 1:STN:280:ByiB1M3pslY%3D A1997WW92500019
17. Sibley RI, Sibley AF. Correlation of digital rectal examination prostate-specific antigen and transrectal ultrasound in prostate carcinoma in African Americans. J Natl Med Assoc 1997; 89: 318-323. 9170832 1:STN:280:ByiA3Mvlslc%3D
18. Oesterling JE, Kumamoto Y, Tsukamoto T et al. Serum prostate-specific antigen in a community-based population of healthy japanese men: Lower values than for similarly aged white men. Br J Urol 1995; 75: 347-353. 7537604 1:STN:280:ByqB2MznslI%3D
19. Reissigl A, Horninger W, Fink K et al. Prostate carcinoma screening in the county of Tyrol, Austria. Cancer 1997; 80: 1818-1829. 10.1002/ (SICI)1097-0142(19971101)80:9<1818::AID-CNCR21>3.0.CO;2-7 9351555 1:STN:280:DyaK1c%2FhtF2hsg%3D%3D A1997YC30600020
20. Tchetgen MB, Osterling JE. The role of prostate-specific antigen in the evaluation of benign prostate hyperplasia. Urol Clin North Am 1994; 22: 333-344.
21. Chu TM, Murphy GP. What's new in tumor markers for prostate cancer?. Urology 1986; 27: 487-491. 2424164 1:STN:280:BimB3snosFY%3D A1986C732800001
22. Guinan P, Bhatti R, Ray P. An evaluation of prostate-specific antigen in prostate cancer. J Urol 1987; 137: 686-689. 2435927 1:STN:280:BiiC28bpsFE%3D
23. Lange PH, Brawer MK. Serum prostate specific antigen: Its use in diagnosis and management of prostate cancer. Urology 1989; 33:(5), 13-17. 2471346 1:STN:280:BiaB28fgslI%3D A1989AB36800003
24. Lange PH. Prostate-specific antigen in diagnosis and management of prostate cancer. Urology 1990; 36: (suppl 5) 25-29. 1700529 1:STN:280:By6D2cbhs1w%3D A1990EJ38900005
25. Brawer M, Chetner M, Beatie J et al. Screening for prostatic carcinoma with prostate specific antigen. J Urol 1992; 147: 841-845. 1371559 1:STN:280:By2C28jkt10%3D
26. Babaian RJ, Mettlin C, Kane R et al. The relationship of prostate-specific antigen to digital rectal examination and transrectal ultrasonography. Cancer 1992; 69: 1195-1200. 1371233 1:STN:280:By2C2Mvls1I%3D A1992HF67200020
27. Brawer MK, Cheli CD, Neaman IE et al. Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate-specific antigen for detecting prostate cancer. J Urol 2000; 163: 1476-1480. 10751861 1:STN:280:DC%2BD3c3hslSisw%3D%3D
28. Catalona WJ, Richie JP, DeKernion JB et al. Comparison of prostate-specific antigen in a screened population. J Urol 1994; 152: 2031-2036. 7525994 1:STN:280:ByqD2MnhtFA%3D
29. Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ - confined prostate cancer is increasing through prostate - specific antigen based screening. JAMA 1993; 270: 948-954. 7688438 1:STN:280:ByyA2cjjvV0%3D A1993LT56700025
30. Richie JP, Catalona WJ, Ahmann FR et al. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology 1993; 42: 365-374. 7692657 1:STN:280:ByuD38rktlY%3D A1993MC62500004
31. Richard MH, Frank DG, Meg Adams C et al. Prostate-specific antigen testing accuracy in community practice. BMC Family Practice 2002; 3: 19.
32. Osterling JE, Jacobsen SJ, Chute CG t al. Serum prostate-specific antigen in a community-based population of healthy men: Establishment of age-specific reference ranges. JAMA 1993; 270: 860-864.
33. Akdas AI, Cevik T, Tarcan L et al. The role of free prostate-specific antigen in the diagnosis of prostate cancer. Br J Urol 1997; 79: 920-923. 9202560 1:CAS:528:DyaK2sXksVKisbc%3D
34. Stamey TA, Hay N, Yang AR et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. New Engl J Med 1987; 317: 909-916. 2442609 1:STN:280:BiiA3Mrislw%3D
35. Christesson A, Bjork T, Nilsson O et al. Serum PSA complexed to alpha-1-anti-chymotrypsin as an indicator of prostate cancer. J Urol 1993; 150: 100-105.
36. Stewart CS, Leibovich BC, Weaver AL, Lieber MA. Prostate cancer diagnosis using a saturation needle biopsy technique after previous netative sextant biopsies. J Urol 2001; 166: 86-91. 11435830 1:STN:280:DC%2BD3MznslGhsg%3D%3D
37. Stamey TA. Editorial comments: Saturation prostate needle biopsy. J Urol 2001; 166: 91-92.
38. Durgan JA, Bostwichk DG, Myers RP et al. The definition and preoperative prediction of clinically insignificant prostate cancer. JAMA 1996; 275: 288-294.